ES Surrey

No ORCID on file · 6 papers in corpus · active 2016-2020

Study types

  • article 6

Condition tags

  • endometriosis 6
article 2020
PDB58 REAL WORLD EVIDENCE ON THE IMPACT OF ELAGOLIX UTILIZATION ON PAIN SYMPTOMS, TREATMENT PATTERNS AND HEALTH RESOURCE USE AMONG ENDOMETRIOSIS PATIENTS IN THE UNITED STATES
·doi:10.1016/j.jval.2020.04.245
article 2018
Impact of Elagolix on Health-Related Quality of Life Among Patients with Moderate to Severe Endometriosis-Associated Pain: Analysis of EQ-5D-5L Data from a Phase III Randomized Controlled Trial
·doi:10.1016/j.jval.2018.04.1014
article 2018
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist
·doi:10.1530/ey.15.15.6

We highlight this paper for 3 reasons. First, remarkably there are few robust data on effective treatment options for endometriosis. Subcutaneous GnRH antagonists are sometimes used off-label, but with very limited evidence. Secondly, the c…

article 2017
Direct healthcare utilization and costs associated with endometriosis among women with medicaid insurance
·doi:10.1016/j.fertnstert.2017.07.291
article 2017
Long-term effect of elagolix on bone mineral density: results from two phase 3 extension studies in women with endometriosis-associated pain
·doi:10.1016/j.fertnstert.2017.07.292
article 2016
Use of elagolix for the management of endometriosis-associated pain: secondary efficacy results from two randomized, placebo-controlled studies
·doi:10.1016/j.fertnstert.2016.07.774